In recent years, it has been reported that claudin-3 was highly expressed in ovarian cancers, but hardly detected in normal ovarian epithelium [5], thereby, claudin-3 was considered to be a promising target for diagnosis and treatment in ovarian cancers [6]. The gene discussed is CLDN3; the disease is ovarian carcinoma.